Insights

Loading spinner
Gathering insights about ITB-MED

ITB-MED Tech Stack

ITB-MED uses 8 technology products and services including Microsoft 365, Veeva Vault, Chart.js, and more. Explore ITB-MED's tech stack below.

  • Microsoft 365
    Email
  • Veeva Vault
    Enterprise Content Management
  • Chart.js
    Javascript Graphics
  • Modernizr
    Javascript Libraries
  • Select2
    Javascript Libraries
  • HSTS
    Security
  • Animate.css
    UI Frameworks
  • Facebook
    Widgets

ITB-MED's Email Address Formats

ITB-MED uses at least 1 format(s):
ITB-MED Email FormatsExamplePercentage
First.Last@itb-med.comJohn.Doe@itb-med.com
50%
First.Last@itb-med.comJohn.Doe@itb-med.com
50%

Frequently Asked Questions

Where is ITB-MED's headquarters located?

Minus sign iconPlus sign icon
ITB-MED's main headquarters is located at 110 East 59th Street 28 New York, New York 10022 United States. The company has employees across 2 continents, including North AmericaEurope.

What is ITB-MED's official website and social media links?

Minus sign iconPlus sign icon
ITB-MED's official website is itb-med.com and has social profiles on LinkedIn.

What is ITB-MED's SIC code NAICS code?

Minus sign iconPlus sign icon
ITB-MED's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ITB-MED have currently?

Minus sign iconPlus sign icon
As of March 2026, ITB-MED has approximately 37 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer (interim) & Chief Operating Officer: M. L.Chief Legal And Compliance Officer: L. Z.Chief Financial Officer: K. G.. Explore ITB-MED's employee directory with LeadIQ.

What industry does ITB-MED belong to?

Minus sign iconPlus sign icon
ITB-MED operates in the Biotechnology Research industry.

What technology does ITB-MED use?

Minus sign iconPlus sign icon
ITB-MED's tech stack includes Microsoft 365Veeva VaultChart.jsModernizrSelect2HSTSAnimate.cssFacebook.

What is ITB-MED's email format?

Minus sign iconPlus sign icon
ITB-MED's email format typically follows the pattern of First.Last@itb-med.com. Find more ITB-MED email formats with LeadIQ.

How much funding has ITB-MED raised to date?

Minus sign iconPlus sign icon
As of March 2026, ITB-MED has raised $67M in funding. .

When was ITB-MED founded?

Minus sign iconPlus sign icon
ITB-MED was founded in 2016.

ITB-MED

Biotechnology ResearchNew York, United States11-50 Employees

ITB-MED is developing the proprietary antagonistic CD2-directed monoclonal antibody, TCD601 (siplizumab), for several indications. ITB-MED is wholly committed to advancing and exploring the potential of TCD601, with a particular focus on its applications in transplantation and autoimmunity. The efforts extend to comprehensive worldwide clinical trials. ITB-MED is actively investigating further preclinical therapies to expand the reach of its novel immune-modulating approaches.

Section iconCompany Overview

Headquarters
110 East 59th Street 28 New York, New York 10022 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $67M

    ITB-MED has raised a total of $67M of funding over 1 rounds. .

  • $10M$25M

    ITB-MED's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $67M

    ITB-MED has raised a total of $67M of funding over 1 rounds. .

  • $10M$25M

    ITB-MED's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.